Quantcast

Latest Clinical trial Stories

2014-08-13 08:28:42

Rigel Reiterates Clinical Focus on Fostamatinib for ITP and IgA Nephropathy SOUTH SAN FRANCISCO, Calif., Aug. 13, 2014 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that R348, its ophthalmic JAK/SYK inhibitor, did not meet the primary or secondary endpoints in a recently completed Phase 2 clinical study in patients with dry eye disease. The endpoints were measured by changes in corneal fluorescein staining, conjunctival staining, tear production and dry...

2014-08-13 08:28:23

Automation will accelerate analysis of blood samples for expanded colorectal cancer screening trial NAMUR, Belgium, Aug. 13, 2014 /PRNewswire/ -- VolitionRx Limited (OTCQB: VNRX), a life sciences company focused on developing blood-based diagnostic tests for different types of cancer, today announced it has installed a Tecan EVO200 automated liquid handling system in its Namur, Belgium laboratory. The Tecan EVO200 is a robot that will significantly accelerate VolitionRx's large scale clinical...

2014-08-12 23:09:28

In support of the Alliance for Clinical Research Excellence and Safety (ACRES) global collaborative model, industry stakeholders have pledged more than $102M in technologies and services to transform the clinical research enterprise and accelerate medicines development, enhancing quality, safety and long-term industry sustainability. (PRWEB) August 12, 2014 Following the recent meeting of a multi-sector global stakeholder consultation on clinical research site-excellence, strategic allies...

2014-08-12 08:31:39

CLEVELAND, Aug. 12, 2014 /PRNewswire-USNewswire/ -- Juventas Therapeutics, Inc., a private clinical-stage company developing a drug-based approach to regenerative medicine today announced that it successfully completed the Phase I arm of the RETRO-HF clinical trial, and fully enrolled the Phase II arm that is evaluating the safety and preliminary clinical efficacy for retrograde infusion of JVS-100 in patients with heart failure....

2014-08-12 08:29:26

Array planning for potential return of MEK inhibitor BOULDER, Colo., Aug. 12, 2014 /PRNewswire/ -- Array BioPharma Inc. (NASDAQ: ARRY) today reported results for the fourth quarter and full year of its fiscal year ending June 30, 2014. http://photos.prnewswire.com/prnvar/20121029/LA02195LOGO Ron Squarer, Chief Executive Officer of Array, noted, "The Array-invented MEK inhibitors, binimetinib and selumetinib, are currently enrolling six Phase 3 trials, and each of our partners has...

2014-08-11 23:06:16

DZS Software Solutions uses results of client feedback to build on a reliable and robust system with ClinPlus® CTMS 2.2. Bound Brook, NJ (PRWEB) August 11, 2014 DZS Software Solutions (DZS), a provider of the ClinPlus® software products and services supporting several aspects of clinical trials, today announced the official release of ClinPlus® CTMS 2.2. This release builds on a reliable and robust system that has gained enormous popularity primarily for its combination...

2014-08-11 23:04:30

New partnership will give better clinical trial access and information to over 100,000 patient influencers. Boston and London (PRWEB) August 11, 2014 TrialReach, the world’s largest provider of clinical research information and patient-clinical trial matching, today announced a new collaboration with WEGO Health, a social network comprised of over 100,000 patient influencers. WEGO Health will expand its TrialShare platform by incorporating TrialReach tools and resources directly so that...

2014-08-11 16:25:35

LONDON, Aug. 11, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Spasticity Global Clinical Trials Review, H2, 2014https://www.reportbuyer.com/product/2280943/Spasticity-Global-Clinical-Trials-Review-H2-2014.htmlSpasticity Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, "Spasticity Global Clinical Trials Review, H2, 2014" provides data on the Spasticity clinical trial scenario. This report provides elemental information and...

2014-08-11 16:25:30

LONDON, Aug. 11, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Spastic Cerebral Palsy Global Clinical Trials Review, H2, 2014https://www.reportbuyer.com/product/2280941/Spastic-Cerebral-Palsy-Global-Clinical-Trials-Review-H2-2014.htmlSpastic Cerebral Palsy Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, "Spastic Cerebral Palsy Global Clinical Trials Review, H2, 2014" provides data on the Spastic Cerebral Palsy clinical...

2014-08-11 16:25:21

LONDON, Aug. 11, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Renal Pain Global Clinical Trials Review, H2, 2014https://www.reportbuyer.com/product/703965/Renal-Pain-Global-Clinical-Trials-Review-H2-2014.htmlRenal Pain Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, "Renal Pain Global Clinical Trials Review, H2, 2014" provides data on the Renal Pain clinical trial scenario. This report provides elemental information and...


Word of the Day
pungle
  • To take pains; labor assiduously with little progress.
This word comes from the Spanish 'pongale,' put it.
Related